Chest pain interventions: Difference between revisions
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
* New-onset [[left ventricular systolic dysfunction ]] ([[ejection fraction]] <40%) | * New-onset [[left ventricular systolic dysfunction ]] ([[ejection fraction]] <40%) | ||
* Newly diagnosed moderate-severe [[ischemia]] on [[stress]] imaging | * Newly diagnosed moderate-severe [[ischemia]] on [[stress]] imaging | ||
*::For high-risk [[patients]] presented with documented [[AMI]] and normal [[epicardial coronary arteries]] on [[CCTA]] or invasive [[ coronary angiography]], or nonobstructive [[CAD]], [[CMR]] and [[echocardiography]] are useful for evaluation of [[nonischemic cardiomyopathy]] or [[myocarditis]]. | |||
==References== | ==References== | ||
Revision as of 08:29, 26 December 2021
|
Chest pain Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chest pain interventions On the Web |
|
Risk calculators and risk factors for Chest pain interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Aisha Adigun, B.Sc., M.D.[3]
Overview
Indications
Common indications of coronary angiography in high risk ACS patients include:
- New ischemic changes on the ECG
- Troponin-confirmed acute myocardial injury
- New-onset left ventricular systolic dysfunction (ejection fraction <40%)
- Newly diagnosed moderate-severe ischemia on stress imaging
- For high-risk patients presented with documented AMI and normal epicardial coronary arteries on CCTA or invasive coronary angiography, or nonobstructive CAD, CMR and echocardiography are useful for evaluation of nonischemic cardiomyopathy or myocarditis.